| Outcome Measures: |
Primary: Change in Haemoglobin A1c (HbA1c) level, Measured in Percentage (%)., From baseline (3 months prior to or on the index date) to 6 months|Change in HbA1c level, Measured in millimoles per mol (mmol/mol), From baseline (3 months prior to or on the index date) to 6 months|Proportion of participants achieving HbA1c less than (<) 7.0%, Measured in percentage of participants., At 6 months | Secondary: Change in HbA1c level, Measured in %., From baseline (3 months prior to or on the index date) to 12 months|Change in HbA1c level, Measured in mmol/mol., From baseline (3 months prior to or on the index date) to 12 months|Proportion of participants achieving HbA1c <7.0%, Measured in percentage of participants., At 12 months|Change in body weight, Measured in kilograms., From baseline (3 months prior to or on the index date) to 12 months|Change in body weight, Measured in kilograms., From baseline (3 months prior to or on the index date) to 6 months|Description of participants with different demographic characteristics, At baseline (12 months prior to or on the index date)|Description of participants with different clinical characteristics, At baseline (36 months prior to or on the index date)|Proportion of participants with different antidiabetic medications, Measured in percentage of participants., At baseline (3 months prior to or on the index date)|Proportion of participants with different non-antidiabetic medications, Measured in percentage of participants., At baseline (3 months prior to or on the index date)
|
